MIRA Pharmaceuticals, Inc. (MIRA)
Develops experimental brain medicines for neurological and psychiatric disorders.
$0.84-0.05%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-45.5%
The outlook
MIRA is trading near its 52-week low, well below both its 50- and 200-day moving averages, signaling a downtrend. Analyst coverage appears thin or unavailable. The current price sits at the extreme lower end of its recent range, reflecting weak momentum.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range1% of the way from its 52-week low to high
Market cap
$35.3M
52-wk high
$2.45
52-wk low
$0.83
50-day avg
$0.96
200-day avg
$1.21
Trailing P/E
—